Divi's Lab.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE361B01024
  • NSEID: DIVISLAB
  • BSEID: 532488
INR
11,200.00
22 (0.2%)
BSENSE

Nov 20

BSE+NSE Vol: 4.15 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Mankind Pharma
Divi's Lab.
Laurus Labs
Aurobindo Pharma
Zydus Lifesci.
Torrent Pharma
Dr Reddy's Labs
Glenmark Pharma
Cipla
Lupin
Sun Pharma.Inds.
Why is Divis Laboratories Ltd ?
1
High Management Efficiency with a high ROE of 16.73%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
With a growth in Operating Profit of 25.85%, the company declared Very Positive results in Sep 26
  • The company has declared positive results for the last 9 consecutive quarters
  • PBDIT(Q) Highest at Rs 1,566.00 cr.
  • NET SALES(Q) Highest at Rs 3,676.00 cr
  • OPERATING PROFIT TO NET SALES(Q) Highest at 42.60%
4
Stock is technically in a Bullish range
  • The technical trend has improved from Mildly Bullish on 03-Nov-26 and has generated 11.67% returns since then
  • Multiple factors for the stock are Bullish like MACD, Bollinger Band, KST, DOW and OBV
5
High Institutional Holdings at 39.55%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to Divi's Lab. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Divi's Lab. for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
Divi's Lab.
73.27%
2.89
25.33%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
10.39%
EBIT Growth (5y)
8.18%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.12
Sales to Capital Employed (avg)
0.65
Tax Ratio
24.05%
Dividend Payout Ratio
36.28%
Pledged Shares
0
Institutional Holding
39.55%
ROCE (avg)
25.30%
ROE (avg)
16.73%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
87
Industry P/E
40
Price to Book Value
16.52
EV to EBIT
71.42
EV to EBITDA
63.53
EV to Capital Employed
18.72
EV to Sales
24.21
PEG Ratio
2.32
Dividend Yield
0.27%
ROCE (Latest)
26.21%
ROE (Latest)
18.99%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Bullish
Bullish
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

24What is working for the Company
PBDIT(Q)

Highest at Rs 1,566.00 cr.

NET SALES(Q)

Highest at Rs 3,676.00 cr

OPERATING PROFIT TO NET SALES(Q)

Highest at 42.60%

PBT LESS OI(Q)

Highest at Rs 1,411.00 cr.

PAT(Q)

Highest at Rs 1,127.00 cr.

EPS(Q)

Highest at Rs 42.53

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Divi's Lab.
Operating Profit (PBDIT) - Quarterly
Highest at Rs 1,566.00 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 1,411.00 cr has Grown at 63.3% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 864.25 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 1,127.00 cr has Grown at 51.3% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 745.08 Cr
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
Highest at Rs 3,676.00 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Net Sales - Quarterly
At Rs 3,676.00 cr has Grown at 30.9% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 2,807.50 Cr
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 42.60%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 1,411.00 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 1,127.00 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 42.53
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)